TrialDiabetes, obesity & metabolism2021

A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity.

Christian L Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.